Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V F Mautner

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Anticancer Research|July 26, 2007
Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1V F Mautner, W Brenner, C Fünsterer, et al.
Clinical Genetics|June 27, 2015
Growth in neurofibromatosis 1 microdeletion patientsX Ning, S Farschtschi, A Jones, et al.
Journal of Medical Genetics|October 22, 2008
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromasT Tucker, J M Friedman, R E Friedrich, et al.
Histopathology|September 19, 2006
Transcription factor AP-2 is expressed in human Schwann cell-derived tumoursA Harder, V-F Mautner, R E Friedrich, et al.
American Journal of Medical Genetics|May 30, 1998
Phenotypic variability associated with 14 splice-site mutations in the NF2 geneL Kluwe, M MacCollin, M Tatagiba, et al.
Neurobiology of Disease|August 14, 1998
Isolation and characterization of Schwann cells from neurofibromatosis type 2 patientsC Rosenbaum, L Kluwe, V F Mautner, et al.
Human Genetics|November 1, 1996
Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesL Kluwe, S Bayer, M E Baser, et al.
The British Journal of Dermatology|May 20, 2003
Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?M Leverkus, L Kluwe, E-M Röll, et al.
Journal of Neuropathology and Experimental Neurology|September 15, 2001
Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomasL Kluwe, C Hagel, M Tatagiba, et al.
Neuropathology and Applied Neurobiology|June 2, 2016
The putative oncogene CPI-17 is up-regulated in schwannomaC Hagel, C Dornblut, A Schulz, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Anticancer Research|July 26, 2007
Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1V F Mautner, W Brenner, C Fünsterer, et al.
Clinical Genetics|June 27, 2015
Growth in neurofibromatosis 1 microdeletion patientsX Ning, S Farschtschi, A Jones, et al.
Journal of Medical Genetics|October 22, 2008
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromasT Tucker, J M Friedman, R E Friedrich, et al.
Histopathology|September 19, 2006
Transcription factor AP-2 is expressed in human Schwann cell-derived tumoursA Harder, V-F Mautner, R E Friedrich, et al.
American Journal of Medical Genetics|May 30, 1998
Phenotypic variability associated with 14 splice-site mutations in the NF2 geneL Kluwe, M MacCollin, M Tatagiba, et al.
Neurobiology of Disease|August 14, 1998
Isolation and characterization of Schwann cells from neurofibromatosis type 2 patientsC Rosenbaum, L Kluwe, V F Mautner, et al.
Human Genetics|November 1, 1996
Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesL Kluwe, S Bayer, M E Baser, et al.
The British Journal of Dermatology|May 20, 2003
Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?M Leverkus, L Kluwe, E-M Röll, et al.
Journal of Neuropathology and Experimental Neurology|September 15, 2001
Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomasL Kluwe, C Hagel, M Tatagiba, et al.
Neuropathology and Applied Neurobiology|June 2, 2016
The putative oncogene CPI-17 is up-regulated in schwannomaC Hagel, C Dornblut, A Schulz, et al.
Pageof 8